Pulmonary hypertension in chronic interstitial lung diseases
نویسندگان
چکیده
منابع مشابه
Pulmonary hypertension in chronic interstitial lung diseases.
Pulmonary hypertension (PH) is a common complication of interstitial lung diseases (ILDs), particularly in idiopathic pulmonary fibrosis and ILD associated with connective tissue disease. However, other lung diseases, such as combined pulmonary fibrosis and emphysema syndrome, pulmonary Langerhans cell histiocytosis, and lymphangioleiomyomatosis, may also include PH in their clinical manifestat...
متن کاملPulmonary hypertension in chronic obstructive and interstitial lung diseases.
The purpose of the present review is to summarize the current knowledge on PH in relation to COPD and ILD from a clinical perspective with emphasis on diagnosis, biomarkers, prevalence, impact, treatment, and practical implications. PH in COPD and ILD is associated with a poor prognosis, and is considered one of the most frequent types of PH. However, the prevalence of PH among patients with CO...
متن کاملPulmonary hypertension in the interstitial lung diseases.
T he interstitial lung diseases, like many chronic lung diseases, may lead to the development of pulmonary hypertension and cor pulmonale. The prevalence of pulmonary hypertension in these diseases is unknown, however. Current data suggest that prevalence varies with the type ofinterstitial disease.'3 In a group of patients with either idiopathic pulmonary fibrosis or interstitial lung disease ...
متن کاملStatins and Pulmonary Hypertension in Chronic Obstructive Lung Disease
Chronic obstructive lung disease (COPD) is a chronic multisystem disease with a considerable burden. One of its most common complications is pulmonary artery hypertension (PAH). It has been demonstrated that the development of PAH is correlated with decreased quality of life and survival. Different medications have been proposed for the treatment of PAH, among which one can name statins. Howeve...
متن کامل[Pulmonary hypertension in chronic lung diseases].
Chronic obstructive lung disease (COPD) and diffuse parenchymal lung diseases (DPLD), including idiopathic pulmonary fibrosis (IPF) and sarcoidosis, are associated with a high incidence of pulmonary hypertension (PH), which is linked with exercise limitation and a worse prognosis. Patients with combined pulmonary fibrosis and emphysema (CPFE) are particularly prone to the development of PH. Ech...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Review
سال: 2013
ISSN: 0905-9180,1600-0617
DOI: 10.1183/09059180.00002713